
Ardent Health fell about 18% premarket after pricing an 8M-share secondary at $14.50, sold entirely by existing holders Equity Group Investments and Ventas. The company receives no proceeds, but it will repurchase 1.5M of the shares with cash on hand; the offering closes Nov. 19. The stock had already slid ~15% after hours on the announcement.